Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT06754839
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Suzhou Hearthill Medical Technology Co.,LTD
- Registry
-
NCT06754839
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06754839. Randomized; no masking; primary purpose treatment. Start 2024-12 (anticipated); primary completion 2025-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)
- Condition
- Coronary Artery Disease
- Condition
- Heart Failure
- Condition
- High-risk PCI (percutaneous coronary intervention)
- Intervention (Device)
- Percutaneous left ventricular assist device(Ventiflow LP)
- Intervention (Device)
- VA-ECMO
- Lead sponsor
- Suzhou Hearthill Medical Technology Co.,LTD
Record details
- Record id
cardio:ct-nct06754839- Content hash
6f06fb8e412d17deffefc969996ee8faaeaf0449d486e9f48afbe38932f86b44